Hang F. Kwok
Taipa, Macao Special Administrative Region
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 149 publications
Enhancing immunotherapy efficacy of hepatocellular carcinoma by inhibiting the key antioxidant factor Nrf2.
Journal: Molecular therapy. Oncology
Published: May 27, 2026
Sexual Dimorphism and Intraspecific Toxin Variation in Crotalus durissus terrificus Venom: Insights from Proteomics, Peptidomics, and Structural Modeling.
Journal: Journal of proteome research
Published: March 23, 2026
Targeted inhibition of Nrf2 potentiates antitumor immunity and enhances the efficacy of immunotherapy in hepatocellular carcinoma.
Journal: Journal for immunotherapy of cancer
Published: March 06, 2026
Elucidating the toxicity of the plasticizer DPhP: Evidence of neurotoxicity and developmental impairment from in vitro to in vivo models.
Journal: Current research in toxicology
Published: March 04, 2026
A Scorpion Venom-Derived Peptide M6 Endowed with Anti-Aging Ability via Enhanced Antioxidant Activity in Cells, Caenorhabditis elegans and Mouse Models.
Journal: International journal of biological sciences
Published: February 16, 2026
Targeting CD39 as a Therapeutic for Cancer Immunotherapy.
Journal: Expert reviews in molecular medicine
Published: January 26, 2026
Discovery of Two Novel Scorpion Venom Peptides Activating TRPML2 to Impair ZIKV Internalization.
Journal: Toxins
Published: January 23, 2026
An AI-derived peptide PCa2 suppresses pancreatic cancer growth via modulation of the ErbB/PI3K/AKT/mTOR/MYC signaling axis.
Journal: Cell communication and signaling : CCS
Published: December 13, 2025
Dendrimers in cancer therapy: emerging clinical design strategies.
Journal: Trends in pharmacological sciences
Published: December 12, 2025
Transgenerational neurotoxicity of plasticizers diisooctyl phthalate (DIOP) in Caenorhabditis elegans.
Journal: Chemico-biological interactions
Published: August 12, 2025
RCC1 knockdown sensitizes drug-resistant colorectal cancer to 5-fluorouracil or doxorubicin by impairing DNA repair.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: August 05, 2025
Prognostic model for lung adenocarcinoma based on experimental drug-resistant cell lines and clinical patients.
Journal: Frontiers in molecular biosciences
Published: June 26, 2025
Last Updated: 09/26/2026